Skip to main content
TipRanks
Go Ultimate75% OFF

Dongsung Pharmaceutical Co., Ltd. (002210) Stock Statistics & Valuation Metrics

Total Valuation

Dongsung Pharmaceutical Co., Ltd. has a market cap or net worth of KRW 96.30B. The enterprise value is KRW 123.80B.

Market Cap
KRW 96.30B
Enterprise Value
KRW 123.80B

Share Statistics

Dongsung Pharmaceutical Co., Ltd. has 96,619,510 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
96,619,510
Owned by Insiders
―
Owned by Institutions
<0.01%

Financial Efficiency

Dongsung Pharmaceutical Co., Ltd.’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -19.94%.

Return on Equity (ROE)
-1.10
Return on Assets (ROA)
-0.15
Return on Invested Capital (ROIC)
-19.94%
Return on Capital Employed (ROCE)
-0.59
Revenue Per Employee
283.94M
Profits Per Employee
-83.83M
Employee Count
307
Asset Turnover
0.52
Inventory Turnover
2.61

Valuation Ratios

The current PE Ratio of Dongsung Pharmaceutical Co., Ltd. is -3.48. Dongsung Pharmaceutical Co., Ltd.’s PEG ratio is -0.04.

PE Ratio
-3.48
PS Ratio
0.30
PB Ratio
1.10
Price to FCF
-0.95
Price to Operating Cash Flow
-3.80
PEG Ratio
-0.04

Income Statement

In the last 12 months, Dongsung Pharmaceutical Co., Ltd. had revenue of 87.17B and earned -25.74B in profits. Earnings per share was -1125.56.

Revenue
87.17B
Gross Profit
36.36B
Operating Income
-22.87B
Pretax Income
-28.69B
Net Income
-25.74B
EBITDA
-20.73B
Earnings Per Share (EPS)
-1125.56

Cash Flow

In the last 12 months, operating cash flow was -25.26B and capital expenditures -906.25M, giving a free cash flow of -26.16B billion.

Operating Cash Flow
-25.26B
Free Cash Flow
-26.16B
Free Cash Flow per Share
-277.87

Dividends & Yields

Dongsung Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-105.09%
Earnings Yield
-12.00%

Stock Price Statistics

Beta
0.02
52-Week Price Change
4.83%
50-Day Moving Average
1262.66
200-Day Moving Average
1127.48
Relative Strength Index (RSI)
28.92
Average Volume (3m)
116.86K

Important Dates

Dongsung Pharmaceutical Co., Ltd. upcoming earnings date is Mar 12, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 12, 2027
Ex-Dividend Date
―

Financial Position

Dongsung Pharmaceutical Co., Ltd. as a current ratio of 0.69, with Debt / Equity ratio of 274.42%

Current Ratio
0.69
Quick Ratio
0.54
Debt to Market Cap
2.88
Net Debt to EBITDA
-2.91
Interest Coverage Ratio
-2.35

Taxes

In the past 12 months, Dongsung Pharmaceutical Co., Ltd. has paid -2.95B in taxes.

Income Tax
-2.95B
Effective Tax Rate
0.10

Enterprise Valuation

Dongsung Pharmaceutical Co., Ltd. EV to EBITDA ratio is -4.02, with an EV/FCF ratio of -0.99.

EV to Sales
0.32
EV to EBITDA
-4.02
EV to Free Cash Flow
-0.99
EV to Operating Cash Flow
-1.03

Balance Sheet

Dongsung Pharmaceutical Co., Ltd. has KRW 37.47B in cash and marketable securities with KRW 38.61B in debt, giving a net cash position of -KRW 1.14B billion.

Cash & Marketable Securities
KRW 37.47B
Total Debt
KRW 38.61B
Net Cash
-KRW 1.14B
Net Cash Per Share
-KRW 11.75
Tangible Book Value Per Share
KRW 925.01

Margins

Gross margin is 41.24%, with operating margin of -10.33%, and net profit margin of -14.04%.

Gross Margin
41.24%
Operating Margin
-10.33%
Pretax Margin
-21.34%
Net Profit Margin
-14.04%
EBITDA Margin
-7.88%
EBIT Margin
-10.33%

Analyst Forecast

The average price target for Dongsung Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-11.67%
EPS Growth Forecast
55.91%

Scores

Smart Score
―
AI Score
45